BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 30813415)

  • 21. An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.
    Leung HC; Chan CC; Poon VK; Zhao HJ; Cheung CY; Ng F; Huang JD; Zheng BJ
    Emerg Microbes Infect; 2015 Apr; 4(4):e22. PubMed ID: 26038770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of pseudoparticles paired with hemagglutinin and neuraminidase from highly pathogenic H5N1 influenza and avian influenza A (H7N9) viruses.
    Zhang F; Wang S; Wang Y; Shang X; Zhou H; Cai L
    Virus Res; 2018 Jul; 253():20-27. PubMed ID: 29859234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of highly pathogenic avian influenza A(H5N1) viruses in Indonesia following the reassortment and acquisition of genes from low pathogenicity avian influenza A virus progenitors.
    Dharmayanti NLPI; Thor SW; Zanders N; Hartawan R; Ratnawati A; Jang Y; Rodriguez M; Suarez DL; Samaan G; Pudjiatmoko ; Davis CT
    Emerg Microbes Infect; 2018 Aug; 7(1):147. PubMed ID: 30131494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptomic characterization of the novel avian-origin influenza A (H7N9) virus: specific host response and responses intermediate between avian (H5N1 and H7N7) and human (H3N2) viruses and implications for treatment options.
    Josset L; Zeng H; Kelly SM; Tumpey TM; Katze MG
    mBio; 2014 Feb; 5(1):e01102-13. PubMed ID: 24496798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemagglutinin amino acids related to receptor specificity could affect the protection efficacy of H5N1 and H7N9 avian influenza virus vaccines in mice.
    Xu L; Bao L; Lau SY; Wu WL; Yuan J; Gu S; Li F; Lv Q; Xu Y; Pushko P; Chen H; Qin C
    Vaccine; 2016 May; 34(23):2627-33. PubMed ID: 27083426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Did the Highly Pathogenic Avian Influenza A(H7N9) Viruses Emerged in China Raise Increased Threat to Public Health?
    Zhu W; Yang L; Shu Y
    Vector Borne Zoonotic Dis; 2019 Jan; 19(1):22-25. PubMed ID: 30222520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive comparison of the fifth-wave highly pathogenic and low-pathogenic H7N9 avian influenza viruses reveals potential threat posed by both types of viruses in mammals.
    He L; Liu D; Hu J; Sun W; Gao R; Shi L; He D; Li B; Wang X; Gu M; Hu S; Liu X; Hu Z; Chen S; Peng D; Liu X
    Transbound Emerg Dis; 2018 Dec; 65(6):1459-1473. PubMed ID: 30014613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Highly Pathogenic Avian H7N9 Influenza Virus Isolated from A Human Is Lethal in Some Ferrets Infected via Respiratory Droplets.
    Imai M; Watanabe T; Kiso M; Nakajima N; Yamayoshi S; Iwatsuki-Horimoto K; Hatta M; Yamada S; Ito M; Sakai-Tagawa Y; Shirakura M; Takashita E; Fujisaki S; McBride R; Thompson AJ; Takahashi K; Maemura T; Mitake H; Chiba S; Zhong G; Fan S; Oishi K; Yasuhara A; Takada K; Nakao T; Fukuyama S; Yamashita M; Lopes TJS; Neumann G; Odagiri T; Watanabe S; Shu Y; Paulson JC; Hasegawa H; Kawaoka Y
    Cell Host Microbe; 2017 Nov; 22(5):615-626.e8. PubMed ID: 29056430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic efficacy of peramivir against H5N1 highly pathogenic avian influenza viruses harboring the neuraminidase H275Y mutation.
    Kobayashi M; Kodama M; Noshi T; Yoshida R; Kanazu T; Nomura N; Soda K; Isoda N; Okamatsu M; Sakoda Y; Yamano Y; Sato A; Kida H
    Antiviral Res; 2017 Mar; 139():41-48. PubMed ID: 28012921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tropism, replication competence, and innate immune responses of influenza virus: an analysis of human airway organoids and ex-vivo bronchus cultures.
    Hui KPY; Ching RHH; Chan SKH; Nicholls JM; Sachs N; Clevers H; Peiris JSM; Chan MCW
    Lancet Respir Med; 2018 Nov; 6(11):846-854. PubMed ID: 30001996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replication and pathogenic potential of influenza A virus subtypes H3, H7, and H15 from free-range ducks in Bangladesh in mammals.
    El-Shesheny R; Feeroz MM; Krauss S; Vogel P; McKenzie P; Webby RJ; Webster RG
    Emerg Microbes Infect; 2018 Apr; 7(1):70. PubMed ID: 29691394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: a model to study intervention strategies.
    Kreijtz JH; Kroeze EJ; Stittelaar KJ; de Waal L; van Amerongen G; van Trierum S; van Run P; Bestebroer T; T Kuiken ; Fouchier RA; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2013 Oct; 31(43):4995-9. PubMed ID: 23816392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic characterization and pathogenicity assessment of highly pathogenic H5N1 avian influenza viruses isolated from migratory wild birds in 2011, South Korea.
    Kwon HI; Song MS; Pascua PN; Baek YH; Lee JH; Hong SP; Rho JB; Kim JK; Poo H; Kim CJ; Choi YK
    Virus Res; 2011 Sep; 160(1-2):305-15. PubMed ID: 21782862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is a highly pathogenic avian influenza virus H5N1 fragment recombined in PB1 the key for the epidemic of the novel AIV H7N9 in China, 2013?
    Chen L; Sun L; Li R; Chen Y; Zhang Z; Xiong C; Zhao G; Jiang Q
    Int J Infect Dis; 2016 Feb; 43():85-89. PubMed ID: 26778522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in Mice.
    Murray J; Martin DE; Hosking S; Orr-Burks N; Hogan RJ; Tripp RA
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38275962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a highly pathogenic avian influenza H5N1 virus isolated from an ostrich.
    Yang P; Dongmei ; Wang C; Tang C; Xing L; Luo D; Zhan Z; Duan Y; Jia W; Peng D; Liu X; Wang X
    Biochem Biophys Res Commun; 2010 Jun; 396(4):973-7. PubMed ID: 20497905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Avian Influenza A (H7N9) viruses isolated from patients with mild and fatal infection differ in pathogenicity and induction of cytokines.
    Zhou J; Guo X; Fang D; Yu Y; Si L; Wang Y; Zeng G; Yan H; Wu J; Ke C; Jiang L
    Microb Pathog; 2017 Oct; 111():402-409. PubMed ID: 28826765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Pandemic Threat of Emerging H5 and H7 Avian Influenza Viruses.
    Sutton TC
    Viruses; 2018 Aug; 10(9):. PubMed ID: 30154345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammalian Pathogenesis and Transmission of Avian Influenza A(H7N9) Viruses, Tennessee, USA, 2017.
    Belser JA; Brock N; Sun X; Jones J; Zanders N; Hodges E; Pulit-Penaloza JA; Wentworth D; Tumpey TM; Davis T; Maines TR
    Emerg Infect Dis; 2018 Jan; 24(1):149-152. PubMed ID: 29260672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prior exposure to immunogenic peptides found in human influenza A viruses may influence the age distribution of cases with avian influenza H5N1 and H7N9 virus infections.
    Komadina N; Sullivan SG; Kedzierska K; QuiƱones-Parra SM; Leder K; McVernon J
    Epidemiol Infect; 2019 Jan; 147():e213. PubMed ID: 31364549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.